可溶性白细胞介素2受体测定在小儿白血病和淋巴瘤的临床意义  

CLINICAL SIGNIFICANCE OF SOLUBLE INTERLEUKIN-2 RECEPTOR IN CHILDREN LEUKEMIA AND LYMPHOMA

作　　者：庞秀英[1] 佟琳如[1] 孙立荣[1] 付芃 李学荣[1] 于秀英[1] 孙波[1] 陈颖[1] 

机构地区：[1]青岛医学院附属医院儿内科,266003

出　　处：《中国小儿血液》1998年第4期145-146,共2页China Child Blood

摘　　要：血清和脑脊液中白细胞介素2受体水平与儿童急性白血病和恶性淋巴瘤的发展有关。在疾病治疗前及复发期，血清白细胞介素2受体明显升高，当发生中枢神经系统浸润时，脑脊液中白细胞介素2受体含量明显升高，因此，血清和脑脊液中可溶性白细胞介素2受体水平可作为疾病活动与否69有效指标。Concentration of soluble interluekin-2 receptor (SIL-2R) in serum and cerebrospinalfluid (CSF) is associated with development of diseases of leukemia and lymphoma in children. High level of serum SIL-2R has been found in untreated and relapse cases. High levelof SIL-2R also exist in CSF when invovement of central nervous system of leukemia and lymphoma happens. Therefore the concentration levels of SIL-2R in serum and CSF can be considered as a valuable critition of activities of leukemia and lymphoma.

关 键 词：活性 白血病 儿童 淋巴瘤 SIL-2R 

分 类 号：R733.04[医药卫生—肿瘤]